发明申请
US20080107655A1 HUMAN ANTI-IFN-GAMMA NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-GAMMA PATHWAY INHIBITORS
有权
人类抗IFN-GAMMA作为选择性IFN-GAMMA途径抑制剂中和抗体
- 专利标题： HUMAN ANTI-IFN-GAMMA NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-GAMMA PATHWAY INHIBITORS
- 专利标题（中）： 人类抗IFN-GAMMA作为选择性IFN-GAMMA途径抑制剂中和抗体
-
申请号： US11962594申请日： 2007-12-21
-
公开(公告)号： US20080107655A1公开(公告)日： 2008-05-08
- 发明人: Andrew Welcher , Hilary Chute , Yue-Sheng Li , Haichun Huang
- 申请人： Andrew Welcher , Hilary Chute , Yue-Sheng Li , Haichun Huang
- 申请人地址： US CA Thousand Oaks US NJ Princeton
- 专利权人： Amgen Inc.,Medarex, Inc.
- 当前专利权人： Amgen Inc.,Medarex, Inc.
- 当前专利权人地址： US CA Thousand Oaks US NJ Princeton
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/18 ; A61P25/00 ; A61P1/00
摘要：
This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-γ) and methods for treating IFN-γ mediated diseases by administering a pharmaceutically effective amount of antibodies to IFN-γ. Methods of detecting the amount of IFN-γ in a sample using antibodies to IFN-γ are also provided.
公开/授权文献
信息查询
